PET Scans for Neurodegenerative Diseases - An Overview

Introduction:

PET scan, or photo emission tomography, is a specialized imaging technique that helps view the function of brain cells in humans. This scan is used in neurodegenerative diseases to identify and monitor the functions of the brain and any notable changes occurring in it. In brain PET, the scan is done using a highly sensitive nuclear medicine that is installed for imaging. This is done by distributing the radioactive particles into the human body and observing the brain activity, which gives us an idea of the brain's functioning capacity.

What Are Neurodegenerative Diseases?

Brain disorders known as neurodegenerative illnesses arise when brain cells gradually begin to malfunction or die. Since brain cells cannot regenerate, this is a dangerous condition that immediately requires medical attention. Approximately 6.2 million people worldwide suffer from these illnesses, which have a relatively high incidence. This medical condition is given great importance and awareness as finding a long-term cure is still in process, and prevention is considered the key. Additionally, neurological conditions worsen with aging, indicating increased importance. Examining the physiological processes of neurodegenerative diseases reveals that the brain's neurons, or peripheral nerves that supply the body's extremities, gradually begin to lose their function. As a result, the disease worsens and impairs a person's physical and mental well-being with no known cure. Some examples of neurodegenerative disorders are Parkinson's disease, Alzheimer's disease, Huntington's disease, motor neuron disease, etc.

How Is PET Scan Carried Out in Neurodegenerative Diseases?

The PET scan of the brain serves as a functional assessment for several functional and pathophysiological changes in the brain. The scan also assesses the brain's amino acids, glucose, and dopamine receptor levels. This is done by ingesting radiotracers (a radioactive, biological component) into the body through the bloodstream, which can specifically bind itself at targeted sites. Although these radioactive traces have no pharmacological effect on the part of the body that helps treat the condition, they are still used to trace levels in case of deficiency. The PET scan is used to identify conditions like tumors, localized inflammation, infection, etc.

How Should the Patient Be Prepared Before a Brain PET?

A patient must drink enough water before a brain PET scan. Patients using the fluorescent dye must fast approximately four to six hours before the study. Also, they need to avoid sleeping pills before the absorption period. These medications can be administered at least half an hour after the radiotracer injection. It is suggested that patients consume plenty of water after the scans to help eliminate the radioactive tracer.

What Are the Brain Conditions in Which PET Scan Is Done?

• Neurodegenerative Disorders: As the neurodegenerative disorder is the capacity of the brain to deteriorate, its ability to function or think properly, PET scans come in favor of help. In conditions like dementia and Alzheimer’s, it is primarily seen in older age patients that can affect both the medical and socioeconomic status. Here, PET scans are helpful in earlier identification of the disease, as well as in predicting the progression of the disease and impacting its severity. The brain PET scan also helps modify the treatment based on the periodic review and disease progression. The glucose levels can identify neurodegenerative disease associated with its pattern of affected areas in the brain. It also acts as a precursor in giving an idea about the disease and ways of managing it for study purposes.

• Conditions Affecting Movements: Many times, patients show up with syndromes resembling Parkinsonian diseases. Although these patients may not have Parkinson's disease, they often show symptoms similar to this condition. When a PET scan is done for Parkinson's disease using fluorodopa (FDOPA), the results are often positive. This is because FDOPA uptake will be preserved in patients with non-parkinsonian disorders. However, when done in patients with Parkinson's disease, there is evidence of corticobasal degeneration, progressive supranuclear palsy, and atrophy of the multiple systems.

• Seizures or Epilepsy: Epilepsy, also clinically called fit, is uncoordinated body movement due to neurological origin. The PET test shows the increase and decrease of glucose metabolism in the brain, which helps manage seizure levels and provides more seizure control.

• Encephalitis: Encephalitis is a type of brain inflammation that can frequently be caused by viruses. The clinical symptoms of this condition include fever, headaches, confusion, seizures, and, in severe circumstances, brain damage. The patterns of the PET scan are susceptible, so based on the timing of the PET scan, it can differentiate between the occurrence of the condition, be it acute, subacute, or chronic.

When Are Complications of Brain PET?

Although there is very little radiation exposure to the body because PET scans only use trace amounts of radioactive materials, there are still certain complications to be aware of, and they are:

1. Caution to be taken in people who are most susceptible to radiation exposure are young children and pregnant women.

2. Patients can get bruises after intravenous injection and experience some discomfort at the injection site.

3. Inflammation or swelling can occur from radioactive material invasion at a particular location.

4. Some patients may experience claustrophobia and anxiety, for which sleeping pills or anxiety medications can be given.

5. Repeated scans can be of concern due to radiation exposure.

Conclusion:

PET (positron emission tomography) scans are a useful diagnostic and therapeutic technique for neurodegenerative conditions. PET scans provide information into the neurological changes associated with conditions like Alzheimer's, Parkinson's, and Huntington's by detecting the metabolic and biochemical processes in the brain using radioactive tracers. Compared to other imaging techniques like MRI, this modality can identify early changes in brain activity. To effectively manage patients and develop new therapies, PET scans must be able to observe the development of diseases and how they respond to treatment. This also helps healthcare professionals to customize therapy that meets the needs of each patient by monitoring changes in the brain's metabolism and binding capacity of the receptor. Although the test can be cost-effective, the precision and extensive data from PET scans make them essential for treating and researching neurodegenerative diseases. By doing this, the technology also has improved patient outcomes and quality of life in the long run.